SCHEMBL9200019

SCHEMBL9200019

COC(=O)Cn1ccc2cc(OC)ccc21

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MTNR1A P48039 6/20 0.60
▸ MTNR1B P49286 6/20 0.60
▸ ATM Q13315 1/20 0.57
▸ HTR2C P28335 1/20 0.55
▸ HDAC6 Q9UBN7 4/20 0.51
▸ HDAC8 Q9BY41 3/20 0.51
▸ HDAC11 Q96DB2 1/20 0.51
▸ MAPT P10636 2/20 0.49
▸ L3MBTL1 Q9Y468 1/20 0.49
▸ TUBB1 Q9H4B7 1/20 0.48
▸ HDAC1 Q13547 3/20 0.47
▸ HDAC3 O15379 2/20 0.47
▸ HDAC2 Q92769 2/20 0.47
▸ NCOR2 Q9Y618 1/20 0.47
▸ HDAC10 Q969S8 1/20 0.47
▸ KDM4E B2RXH2 1/20 0.46
▸ ALDH1A1 P00352 1/20 0.46
▸ HPGD P15428 1/20 0.46
▸ SMN1; SMN2 Q16637 1/20 0.46
▸ HSD17B10 Q99714 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29138523 0.87 MTNR1A (0.56) MTNR1AMTNR1BATMHTR2CHDAC6
SCHEMBL14876186 0.86 MTNR1A (0.58) MTNR1AMTNR1BHTR2CHDAC6HDAC8
SCHEMBL19148282 0.85 MTNR1A (0.64) MTNR1AMTNR1BHTR2CHDAC6HDAC8
SCHEMBL19674140 0.85 ATM (0.57) MTNR1AMTNR1BATMHTR2CHDAC6
SCHEMBL10321465 0.85 MTNR1A (0.56) MTNR1AMTNR1BHTR2CHDAC6HDAC8
SCHEMBL5449877 0.85 ATM (0.57) MTNR1AMTNR1BATMHDAC6HDAC8
SCHEMBL2001889 0.84 PPARD (0.51) MTNR1AMTNR1BATMHDAC6HDAC8
SCHEMBL5637363 0.84 ATM (0.56) MTNR1AMTNR1BATMHTR2CHDAC6
SCHEMBL21810428 0.84 NTSR1 (0.57) MTNR1AMTNR1BATMHTR2CHDAC6
SCHEMBL14876504 0.84 NTSR1 (0.57) MTNR1AMTNR1BATMHTR2CHDAC6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2768822-B1 DERIVATIVES OF 1-PHENYL-2-PYRIDINYL ALKYL ALCOHOLS AS PHOSPHODIESTERASE INHIBITORS CHIESI FARM SPA (IT) 2017-12-06 — — EP disclosed
EP-2768822-B1 DERIVATIVES OF 1-PHENYL-2-PYRIDINYL ALKYL ALCOHOLS AS PHOSPHODIESTERASE INHIBITORS CHIESI FARM SPA (IT) 2017-12-06 — — EP disclosed
US-9024027-B2 Derivatives of 1-phenyl-2-pyridinyl alkyl alcohols as phosphodiesterase inhibitors CHIESI FARMACEUTICI S.P.A. (IT) 2015-05-05 — — US disclosed
US-9024027-B2 Derivatives of 1-phenyl-2-pyridinyl alkyl alcohols as phosphodiesterase inhibitors CHIESI FARMACEUTICI S.P.A. (IT) 2015-05-05 — — US disclosed
US-9024027-B2 Derivatives of 1-phenyl-2-pyridinyl alkyl alcohols as phosphodiesterase inhibitors CHIESI FARMACEUTICI S.P.A. (IT) 2015-05-05 — — US disclosed
EP-2768822-A2 DERIVATIVES OF 1-PHENYL-2-PYRIDINYL ALKYL ALCOHOLS AS PHOSPHODIESTERASE INHIBITORS Chiesi Farmaceutici S.p.A. (IT) 2014-08-27 — — EP disclosed
US-20130102576-A1 DERIVATIVES OF 1-PHENYL-2-PYRIDINYL ALKYL ALCOHOLS AS PHOSPHODIESTERASE INHIBITORS CHIESI FARMACEUTICI S.P.A. (IT) 2013-04-25 — — US disclosed
US-20130102576-A1 DERIVATIVES OF 1-PHENYL-2-PYRIDINYL ALKYL ALCOHOLS AS PHOSPHODIESTERASE INHIBITORS CHIESI FARMACEUTICI S.P.A. (IT) 2013-04-25 — — US disclosed
WO-2013057013-A2 DERIVATIVES OF 1-PHENYL-2-PYRIDINYL ALKYL ALCOHOLS AS PHOSPHODIESTERASE INHIBITORS CHIESI FARMACEUTICI S.P.A. (IT) 2013-04-25 — — WO disclosed
WO-2013057013-A2 DERIVATIVES OF 1-PHENYL-2-PYRIDINYL ALKYL ALCOHOLS AS PHOSPHODIESTERASE INHIBITORS CHIESI FARMACEUTICI S.P.A. (IT) 2013-04-25 — — WO disclosed
US-20130102576-A1 DERIVATIVES OF 1-PHENYL-2-PYRIDINYL ALKYL ALCOHOLS AS PHOSPHODIESTERASE INHIBITORS CHIESI FARMACEUTICI S.P.A. (IT) 2013-04-25 — — US disclosed
EP-0489458-B1 Hydroxyquinolone derivatives MERCK SHARP & DOHME (GB) 1995-06-07 — — EP disclosed
US-5252584-A Antagonist for treating nervous system disorders MERCK SHARP & DOHME LIMITED (GB) 1993-10-12 — — US disclosed
EP-0489458-A1 Hydroxyquinolone derivatives MERCK SHARP & DOHME LTD. (GB) 1992-06-10 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130102576-A1 DERIVATIVES OF 1-PHENYL-2-PYRIDINYL ALKYL ALCOHOLS AS PHOSPHODIESTERASE INHIBITORS PDE4A, PDE3A, PDE4B MTNR1A 2080/4885MTNR1B 1577/4885ATM 2329/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback